Vanda Pharmaceuticals Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
11.00
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.09
|
0.06
|
-0.03
|
-33.33%
|
|
2022-06-30
|
0.11
|
0.05
|
-0.06
|
-54.55%
|
|
2022-03-31
|
-0.01
|
-0.11
|
-0.10
|
-1000.00%
|
|
2021-12-31
|
0.09
|
0.12
|
0.03
|
33.33%
|
|
2021-09-30
|
0.18
|
0.14
|
-0.04
|
-22.22%
|
|
2021-06-30
|
0.14
|
0.17
|
0.03
|
21.43%
|
|
2021-03-31
|
0.15
|
0.15
|
0.00
|
0.00%
|
|
2020-12-31
|
0.14
|
0.15
|
0.01
|
7.14%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.00
|
|
2021-12-31
|
0.58
|
|
2020-12-31
|
0.43
|
|
2019-12-31
|
2.12
|
|
2018-12-31
|
0.47
|
|
2017-12-31
|
-0.34
|
|
2016-12-31
|
-0.42
|
|
2015-12-31
|
-0.94
|
|
2014-12-31
|
-1.37
|
|
2013-12-31
|
-0.66
|
|
2012-12-31
|
-0.98
|
|
2011-12-31
|
-0.36
|
|
2010-12-31
|
0.25
|
|
2009-12-31
|
-1.32
|
|
2008-12-31
|
-1.92
|
|
2007-12-31
|
-2.81
|
|
2006-12-31
|
-387.81
|